The United States Food and Drug Administration (US FDA) released a detailed report today (April 10) on the ten procedural observations it had made on Alkem Laboratories' Baddi unit last month.
FDA Issues form 483 to Alkem Laboratories Limited
Alkem Laboratories sinks 3 percent on US FDA`s 10 observations for Himachal unit
SKCDA asks Alkem to recall anti-reflux drug PAN-D which are in circulation with fake batch numbers
Alkem Lab`s Generic Mirabegro Receives Approval in the U.S.
Heritage Global Partners, New Mill Capital, Federal Equipment Company
Alkem Laboratories said it completed the sale of St. Louis manufacturing facility situated in USA owned by S&B Pharma, a step-down subsidiary of the company, for a consideration of $7.96 million.
Alkem Lab`s Generic Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Receives Approval in the U.S.
USFDA inspection at Alkem Lab API manufacturing facility located at Mandva
Alkem`s Generic Azilsartan Medoxomil, Chlorthalidone Receives Approval in the U.S.